135 related articles for article (PubMed ID: 20810027)
1. Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism.
Fernagut PO; Barraud Q; Bezard E; Ghorayeb I; Tison F
Neurol Res; 2010 Dec; 32(10):1050-3. PubMed ID: 20810027
[TBL] [Abstract][Full Text] [Related]
2. Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys.
Ghorayeb I; Fernagut PO; Stefanova N; Wenning GK; Bioulac B; Tison F
Neurosci Lett; 2002 Dec; 335(1):34-8. PubMed ID: 12457736
[TBL] [Abstract][Full Text] [Related]
3. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
Ghorayeb I; Fernagut PO; Aubert I; Bezard E; Poewe W; Wenning GK; Tison F
Mov Disord; 2000 May; 15(3):531-6. PubMed ID: 10830420
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
[TBL] [Abstract][Full Text] [Related]
5. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.
Armentero MT; Fancellu R; Nappi G; Bramanti P; Blandini F
Neurobiol Dis; 2006 Apr; 22(1):1-9. PubMed ID: 16289868
[TBL] [Abstract][Full Text] [Related]
6. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
7. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
8. In vivo models of multiple system atrophy.
Fernagut PO; Ghorayeb I; Diguet E; Tison F
Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
[TBL] [Abstract][Full Text] [Related]
9. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
[TBL] [Abstract][Full Text] [Related]
10. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
[TBL] [Abstract][Full Text] [Related]
11. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease.
Winter C; Hosmann K; Harnack D; Meissner W; Paul G; Morgenstern R; Kupsch A
Synapse; 2006 Jul; 60(1):69-80. PubMed ID: 16598703
[TBL] [Abstract][Full Text] [Related]
13. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T
Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease.
Meissner W; Guigoni C; Cirilli L; Garret M; Bioulac BH; Gross CE; Bezard E; Benazzouz A
Eur J Neurosci; 2007 Mar; 25(5):1492-500. PubMed ID: 17425575
[TBL] [Abstract][Full Text] [Related]
15. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
[TBL] [Abstract][Full Text] [Related]
16. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
Masilamoni GJ; Groover O; Smith Y
Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
[TBL] [Abstract][Full Text] [Related]
17. Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
Morissette M; Samadi P; Hadj Tahar A; Bélanger N; Di Paolo T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):446-54. PubMed ID: 20026151
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
[TBL] [Abstract][Full Text] [Related]
19. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.
Wallace BA; Ashkan K; Heise CE; Foote KD; Torres N; Mitrofanis J; Benabid AL
Brain; 2007 Aug; 130(Pt 8):2129-45. PubMed ID: 17584773
[TBL] [Abstract][Full Text] [Related]
20. Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.
Ugrumov MV; Khaindrava VG; Kozina EA; Kucheryanu VG; Bocharov EV; Kryzhanovsky GN; Kudrin VS; Narkevich VB; Klodt PM; Rayevsky KS; Pronina TS
Neuroscience; 2011 May; 181():175-88. PubMed ID: 21382448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]